# Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa

> **NCT00204685** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 540 (—)

## Conditions studied

- Long Term Ventilation

## Interventions

- **DRUG:** dornase alfa

## Key facts

- **NCT ID:** NCT00204685
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 540 (—)
- **Last updated:** 2006-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00204685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00204685, "Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00204685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*